Jin Medical International (ZJYL) Debt to Equity (2023 - 2025)
Jin Medical International (ZJYL) has disclosed Debt to Equity for 3 consecutive years, with $6.37 as the latest value for Q3 2025.
- Quarterly Debt to Equity rose 1505.32% to $6.37 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.37 through Sep 2025, up 1505.32% year-over-year, with the annual reading at $6.37 for FY2025, 1505.32% up from the prior year.
- Debt to Equity hit $6.37 in Q3 2025 for Jin Medical International, up from $0.4 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $6.37 in Q3 2025 to a low of $0.17 in Q3 2023.
- Historically, Debt to Equity has averaged $2.31 across 3 years, with a median of $0.4 in 2024.
- Biggest five-year swings in Debt to Equity: soared 131.19% in 2024 and later surged 1505.32% in 2025.
- Year by year, Debt to Equity stood at $0.17 in 2023, then skyrocketed by 131.19% to $0.4 in 2024, then skyrocketed by 1505.32% to $6.37 in 2025.
- Business Quant data shows Debt to Equity for ZJYL at $6.37 in Q3 2025, $0.4 in Q3 2024, and $0.17 in Q3 2023.